Cardiff Oncology's Onvansertib shows promise in treating RAS-mutated cancers, especially mCRC. See why I rate CRDF stock as a ...

One of television's raunchiest comedic sports shows is set to make a comeback thanks to Amazon preparing to revitalize in the program in the near future. Blue Mountain State only spent three seasons ...

Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...

Post-surgical adjuvant nivolumab (Opdivo) improved survival outcomes in muscle-invasive bladder cancer (MIBC), regardless of ...

ARLINGTON, Va. - Leonardo DRS, Inc. (NASDAQ: DRS), a defense technology provider with a market capitalization of $18.3 ...

Under the contract Leonardo DRS will provide its ruggedized C4I Battle Management System (BMS) hardware and is the lead integrator for the technology. The work includes integrating BMS software, cyber ...

Intravenous Opdivo, with $2.48 billion in sales, topped the list of precision oncology products in BMS's growth portfolio.

Bristol Myers Squibb will make even deeper cuts to its organization to enhance efficiencies as it faces the 2028 loss of ...

Inc. (Nasdaq: TSVT) today provided full-year Abecma® (idecabtagene vicleucel; ide-cel) sales results for 2024, in partnership with Brist ...